within Pharmacolibrary.Drugs.ATC.J;

model J01DD01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 5.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.021,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of serious bacterial infections, including those caused by susceptible Gram-negative and some Gram-positive bacteria. It is approved and widely used in clinical practice, especially for severe infections such as sepsis, pneumonia, urinary tract infections, and meningitis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported from studies in healthy adult subjects; single dose intravenous administration.</p><h4>References</h4><ol><li><p>Hartman, SJF, et al., &amp; de Wildt, SN (2022). Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children. <i>The Journal of antimicrobial chemotherapy</i> 77(6) 1725–1732. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac095&quot;>10.1093/jac/dkac095</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35383374/&quot;>https://pubmed.ncbi.nlm.nih.gov/35383374</a></p></li><li><p>Altayban, A, et al., &amp; Al-Nazawi, M (2020). Cefotaxime pharmacokinetics in Arabian camel (Camelus dromedarius) calves after single intravenous injection. <i>Tropical animal health and production</i> 52(2) 887–891. DOI:<a href=&quot;https://doi.org/10.1007/s11250-019-02080-0&quot;>10.1007/s11250-019-02080-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31696417/&quot;>https://pubmed.ncbi.nlm.nih.gov/31696417</a></p></li><li><p>Jumpertz, M, et al., &amp; Cassir, N (2022). Subcutaneously administered antibiotics: a review. <i>The Journal of antimicrobial chemotherapy</i> 78(1) 1–7. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac383&quot;>10.1093/jac/dkac383</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36374566/&quot;>https://pubmed.ncbi.nlm.nih.gov/36374566</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DD01;
